Maureen M. O’Brien

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 597 citations · Full text

Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery

Robert J. Anderson, Maureen M. O’Brien, Samantha MaWhinney et al. · Kidney International · 1999 · 235 citations

Hemodialysis, Urology, Renal Function +10

Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus

Joel A. Ernster, Cosimo G. Sciotto, Maureen M. O’Brien et al. · The Laryngoscope · 2007 · 229 citations

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Deepa Bhojwani, Richard Sposto, Nirali N. Shah et al. · Leukemia · 2018 · 202 citations · Full text

Inotuzumab Ozogamicin, Hematological Malignancy, Oncology +15

Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

Laura B. Ramsey, Frank M. Balis, Maureen M. O’Brien et al. · The Oncologist · 2017 · 199 citations · Full text